Haoxi Health Technology Ltd (HAO)
As-reported financials and SEC filings for Haoxi Health Technology Ltd. The latest annual period is FY2026. Financial statements come straight from the company’s EDGAR filings; valuation figures such as P/E and market cap use market data.
About Haoxi Health Technology Ltd
Haoxi Health Technology Ltd is a Cayman Islands holding company that operates through its subsidiary, Beijing Haoxi Digital Technology Co., Ltd., in China. The company conducts its business primarily in Renminbi and reports its consolidated financial statements in U.S. dollars. Haoxi Health Technology's Class A Ordinary Shares trade on the Nasdaq Capital Market under the symbol HAO.
Snapshot
Fundamentals are from SEC filings for FY2026, the latest annual period (ended June 30, 2026). P/E and market cap are derived from stored market prices, last retrieved on a rolling basis and typically within the past week.
What changed at Haoxi Health Technology
- Revenue grew 67.1% to $55M in FY2026, after a 32.4% decline the year before.
- Operating margin is now a 17.6% loss in FY2026, from 1.7% in FY2022.
- Net income turned to a $10M loss in FY2026, from a $4M profit in FY2025.
Computed from the as-reported figures in the statements below. A change we cannot state from filed figures is left out rather than estimated.
Peer comparison
Where Haoxi Health Technology’s fundamentals sit among the 214 Communication Services companies. Each figure is ranked only against peers that report it, from lowest (left) to highest (right).
Haoxi Health Technology’s gross margin of 1.1% ranks in the 2nd percentile of the 103 Communication Services companies reporting it. Haoxi Health Technology’s revenue growth of +67.1% ranks in the 93rd percentile of the 207 Communication Services companies reporting it.
No reported insider transactions (codes P/S) in the last 90 days. For context, about 15% of companies in the universe saw any reported insider purchase (code P) in the same window. Browse insider activity →
Percentiles describe where a figure sits among sector peers reporting it (100th = highest). They are position within a peer group, not a rating, and not investment advice. Short interest ranking uses days to cover from FINRA Consolidated Short Interest data; FINRA is the owner and source of that data, included at no additional charge.
Recent insider activity
Non-derivative buys and sells (codes P/S) reported by officers, directors and 10% owners on SEC Form 4.
| Trade date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
2026-05-19 filed 2026-05-20 | Zhen FanCEO & Chairman | Buy | 40.0M | $0.02 | $720K |
Reported non-derivative purchases and sales (codes P/S), which may be open-market or private. Excludes option exercises, grants, and shares withheld for taxes. Dates shown are the trade date; a Form 4 can be filed days to years later. A sale can be routine (e.g. a pre-set 10b5-1 plan), so read individual transactions in context. From SEC Form 4. Not investment advice.
Short interest
Total shares sold short as of each twice-monthly FINRA settlement. Rising short interest means more investors are positioned against the stock; days to cover estimates how many trading days of average volume that position represents.
| Settlement | Shares short | Change | Days to cover |
|---|---|---|---|
| 2026-09-30 | 24.6K | +8.8% | 1.00 |
| 2026-09-15 | 22.6K | -25.3% | 1.00 |
| 2026-08-31 | 30.3K | +166.1% | 1.00 |
| 2026-08-14 | 11.4K | -91.9% | 1.00 |
| 2026-07-31 | 140.7K | -74.2% | 1.00 |
| 2026-07-15 | 544.9K | +810.7% | 1.00 |
| 2026-06-30 | 59.8K | -60.5% | 1.00 |
| 2026-06-15 | 151.4K | +121.6% | 1.00 |
Source: FINRA Consolidated Short Interest. FINRA is the owner and source of the FINRA-supplied data, which is included at no additional charge for your own personal or professional use; republishing or redistributing it is not permitted. Settlement dates are shown; FINRA publishes each settlement about nine business days later, so the latest figure can be two to four weeks old. Not presented as a percentage of float. No FINRA endorsement of this product is implied. Not investment advice.
Income statement (as reported)
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | $54.8M | $32.8M | $48.5M | $28.2M | $16.2M |
| Gross profit | |||||
| Operating income | $-9.7M | $-2.0M | $1.7M | $1.2M | $268,768 |
| Net income | $-9.5M | $3.9M | $1.3M | $969,752 | $244,587 |
| Diluted EPS | $-386.40 |
Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (tap or hover a figure to see how it was calculated or what was filed). Full details: where the numbers come from.
Balance sheet (as reported)
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Cash and equivalents | $10.9M | $8.6M | $6.7M | $1.2M | $293,511 |
| Current assets | $16.8M | $19.6M | $15.4M | $3.7M | — |
| Total assets | $21.6M | $21.6M | $15.5M | $4.5M | — |
| Current liabilities | $3.7M | $3.9M | $3.9M | $2.6M | — |
| Long-term debt | — | $307,323 | $301,678 | $249,107 | — |
| Total liabilities | $3.7M | $4.2M | $4.2M | $2.9M | — |
| Total equity | $17.9M | $17.4M | $11.3M | $1.6M | $-1.5M |
Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (tap or hover a figure to see how it was calculated or what was filed). Full details: where the numbers come from.
Cash flow (as reported)
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Operating cash flow | $-2.6M | $-3.4M | $-747,576 | $-872,132 | $-675,361 |
| Capital expenditure | — | — | $55,367 | $45,500 | $8,698 |
| Free cash flow | — | — |
Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (tap or hover a figure to see how it was calculated or what was filed). Full details: where the numbers come from.
Company facts
Selected SEC filings
Largest Communication Services peers
Monitor HAO
Get an alert when Haoxi Health Technology files something material, see which superinvestors own it, and ask its filings a question with cited answers.
Monitor HAO freeIncludes one free filing-grounded research answer. Or check your whole portfolio, no account needed.
Data sourced from SEC EDGAR. Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only. Not investment advice.